TABLE 4.
AA women |
HA women |
||||||||
Low intake (≤0.164 g/d; n = 2154) |
High intake (≥0.291 g/d; n = 2120) |
Low intake (≤0.185 g/d; n = 1015) |
High intake (≥0.313 g/d; n = 954) |
||||||
Locus | SNP | OR (95% CI) | P | OR (95% CI) | P (FDR-adjusted P) | OR (95% CI) | P (FDR q) | OR (95% CI) | P (FDR-adjusted P) |
KCNJ11 | rs1800467 | 0.97 (0.46, 2.04) | 0.93 | 1.13 (0.55, 2.32) | 0.74 | 1.11 (0.66, 1.86) | 0.70 | 2.50 (1.50, 4.28) | <0.001 (0.01)* |
CLDN19 | rs11590362 | 1.24 (0.79, 1.93) | 0.34 | 1.23 (0.80, 1.88) | 0.34 | 2.01 (1.20, 3.37) | 0.01 (0.04)** | 1.38 (0.79, 2.41) | 0.26 |
SLC41A1 | rs823154 | 1.06 (0.9, 1.26) | 0.47 | 1.02 (0.85, 1.23) | 0.84 | 1.46 (1.10, 1.86) | 0.002 (0.04)** | 1.01 (0.75, 1.37) | 0.93 |
CNNM1 | rs6584273 | 0.88 (0.74, 1.06) | 0.18 | 0.71 (0.59, 0.87) | <0.001 (0.04)** | 0.93 (0.52, 1.66) | 0.80 | 0.88 (0.46, 1.71) | 0.71 |
NIPA2 | rs7170784 | 1.05 (0.88, 1.26) | 0.58 | 0.94 (0.77, 1.13) | 0.50 | 1.07 (0.86, 1.34) | 0.55 | 0.62 (0.47, 0.80) | <0.001 (0.01)** |
NIPA2 | rs8028189 | 1.05 (0.88, 1.26) | 0.60 | 0.93 (0.77, 1.13) | 0.46 | 1.08 (0.87, 1.35) | 0.48 | 0.65 (0.50, 0.84) | 0.001 (0.01)* |
MMGT1 | rs5929706 | 0.89 (0.60, 1.32) | 0.57 | 0.73 (0.47, 1.14) | 0.17 | 4.66 (1.50, 14.3) | 0.01 (0.05)** | 1.42 (0.29, 6.90) | 0.67 |
MMGT1 | rs5930817 | 1.09 (0.83, 1.43) | 0.54 | 0.90 (0.66, 1.23) | 0.52 | 3.10 (1.40, 6.85) | 0.01 (0.05)** | 0.88 (0.19, 4.03) | 0.87 |
ORs and 95% CIs were computed by using additive model with multivariate logistic regression models and were adjusted for age, region, and 3 principal components of global ancestry. *FDR-adjusted P ≤ 0.01; **FDR-adjusted P ≤ 0.05. AA, African American; FDA, false discovery rate; HA, Hispanic American; SHARe, SNP Health Association Resource; SNP, single nucleotide polymorphism WHI, Women’s Health Initiative.